A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Cynosure Expands Best-In-Class Potenza™ RF Microneedling System

Cynosure announced today the U.S. launch of its one-of-a-kind Fusion Tip, the newest addition to its best-in-class Potenza™ radiofrequency (RF) microneedling system.

With its dual-air chamber design, the Fusion Tip captures and releases air towards the skin with each pulse, enhancing the penetration of topicals into the skin by 67% for maximum results.

“We’re constantly challenging ourselves to drive innovation forward and deliver differentiated technologies that allow our customers to provide better, more customizable treatments for their patients,” said Todd Tillemans, Chief Executive Officer of Cynosure. “The Fusion Tip is the first and only RF microneedling tip on the market designed to enhance the penetration of topicals deeper into the dermis, improving the quality of your skin. This is a real game changer for RF microneedling and we’re proud to be at the forefront of this next-level technology.”

The Fusion Tip is the latest addition to Cynosure’s Potenza system, the world’s first 4-mode RF microneedling device, which uses ultrafine needles and radiofrequency energy to penetrate the top layer of the skin, triggering the body’s natural healing process to regenerate new collagen and elastin. Unlike other treatments on the market, Potenza treatments can be performed on all skin types, anywhere on the body and any time of year. Now with the single-use, disposable Fusion Tip, practitioners can maximize topical penetration while tightening the skin through soft tissue coagulation, revolutionizing the standard microneedling treatment.

“Potenza’s new Fusion Tip enables me to confidently deliver topicals deeper in the dermis, allowing me to reach where it matters most,” said Dr. Deanne Mraz Robinson of Modern Dermatology in Westport, CT. “By enhancing the penetration of topicals into the skin, I am able to maximize patient results.”

Of the Potenza system’s four modes (monopolar or bipolar, delivered at either 1 MHz or 2 MHz frequency), the Fusion Tip operates in monopolar at 1 MHz for deep and wide RF delivery and enhanced tissue engagement and topical penetration. While three to five treatments at roughly four to six weeks apart are recommended, patients may notice improvements in their skin after the first or second treatment and will continue to see improvements six to 12 months post-treatment.

The Fusion Tip is commercially available in the U.S. and only compatible with Cynosure’s Potenza device.

SourceCynosure
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy